Combinatorial Chemistry

In drug development, researchers use combinatorial chemistry to rapidly synthesize a large number of different molecules and screen them against various targets. This discipline has dramatically accelerated the pace of pharmaceutical discovery and development, and drug synthesis.

SRI's Center for Advanced Drug Research applies combinatorial chemistry to the design and validation of biochemical and cellular screening processes.

Press Releases

Jia-Hwa Fang

Jia-Hwa Fang, Ph.D., has joined SRI Biosciences as Director of Clinical Manufacturing. In this new role, he will lead a team to transfer and scale-up R&D, Good Laboratory Practice (GLP), and pilot formulations for early stage clinical trial materials.